Literature DB >> 17668421

T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.

A Farini1, M Meregalli, M Belicchi, M Battistelli, D Parolini, G D'Antona, M Gavina, L Ottoboni, G Constantin, R Bottinelli, Y Torrente.   

Abstract

Abnormal connective tissue proliferation following muscle degeneration is a major pathological feature of Duchenne muscular dystrophy (DMD), a genetic myopathy due to lack of the sarcolemmal dystrophin protein. Since this fibrotic proliferation is likely to be a major obstacle to the efficacy of future therapies, research is needed to understand and prevent the fibrotic process in order to develop an effective treatment. Murine muscular dystrophy (mdx) is genetically homologous to DMD, and histopatological alterations are comparable to those of the muscles of patients with DMD. To investigate the development of fibrosis, we bred the mdx mouse with the scid immunodepressed mouse and analysed fibrosis histologically; we used ELISA analysis to determine TGF-beta1 expression. Significant reduction of fibrosis and TGF-beta1 expression was found in the muscles of the scid/mdx mice. However, we observed similar centrally located nuclei, necrosis, muscle degeneration and muscle force compared to the mdx animals. These data demonstrate a correlation between the absence of B and T lymphocytes and loss of fibrosis accompanied by reduction of TGF-beta1, suggesting the importance of modulation of the immune system in DMD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668421     DOI: 10.1002/path.2213

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  50 in total

1.  Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle.

Authors:  Martin Steinberger; Michael Föller; Silke Vogelgesang; Mirjam Krautwald; Martin Landsberger; Claudia K Winkler; Joachim Kasch; Ernst-Martin Füchtbauer; Dietmar Kuhl; Jakob Voelkl; Florian Lang; Heinrich Brinkmeier
Journal:  Pflugers Arch       Date:  2014-11-14       Impact factor: 3.657

Review 2.  The companions: regulatory T cells and gene therapy.

Authors:  Saman Eghtesad; Penelope A Morel; Paula R Clemens
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

Review 3.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

Review 4.  What do mouse models of muscular dystrophy tell us about the DAPC and its components?

Authors:  Charlotte Whitmore; Jennifer Morgan
Journal:  Int J Exp Pathol       Date:  2014-09-30       Impact factor: 1.925

Review 5.  Tissue Tregs.

Authors:  Marisella Panduro; Christophe Benoist; Diane Mathis
Journal:  Annu Rev Immunol       Date:  2016-05-20       Impact factor: 28.527

6.  Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.

Authors:  Luca Bello; Kevin M Flanigan; Robert B Weiss; Pietro Spitali; Annemieke Aartsma-Rus; Francesco Muntoni; Irina Zaharieva; Alessandra Ferlini; Eugenio Mercuri; Sylvie Tuffery-Giraud; Mireille Claustres; Volker Straub; Hanns Lochmüller; Andrea Barp; Sara Vianello; Elena Pegoraro; Jaya Punetha; Heather Gordish-Dressman; Mamta Giri; Craig M McDonald; Eric P Hoffman
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

7.  Degenerative and regenerative features of myofibers differ among skeletal muscles in a murine model of muscular dystrophy.

Authors:  Teppei Ikeda; Osamu Ichii; Saori Otsuka-Kanazawa; Teppei Nakamura; Yaser Hosny Ali Elewa; Yasuhiro Kon
Journal:  J Muscle Res Cell Motil       Date:  2016-07-29       Impact factor: 2.698

Review 8.  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Authors:  Nicholas P Evans; Sarah A Misyak; John L Robertson; Josep Bassaganya-Riera; Robert W Grange
Journal:  PM R       Date:  2009-08       Impact factor: 2.298

9.  Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta.

Authors:  Sylvia A Vetrone; Encarnacion Montecino-Rodriguez; Elena Kudryashova; Irina Kramerova; Eric P Hoffman; Scot D Liu; M Carrie Miceli; Melissa J Spencer
Journal:  J Clin Invest       Date:  2009-05-18       Impact factor: 14.808

10.  Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy.

Authors:  Andrea Farini; Clementina Sitzia; Barbara Cassani; Letizia Cassinelli; Rosita Rigoni; Federica Colleoni; Nicola Fusco; Stefano Gatti; Pamela Bella; Chiara Villa; Filomena Napolitano; Rita Maiavacca; Silvano Bosari; Anna Villa; Yvan Torrente
Journal:  Mol Ther       Date:  2016-08-10       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.